Therasense Valuation
| THER Stock | USD 0.0001 0.00 0.00% |
Therasense seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Therasense from inspecting the company fundamentals such as Shares Owned By Insiders of 83.61 %, return on asset of -169.9, and Price To Book of 0.86 X as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Therasense's price fluctuation is very steady at this time. Calculation of the real value of Therasense is based on 3 months time horizon. Increasing Therasense's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Therasense pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Therasense. Since Therasense is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Therasense Pink Sheet. However, Therasense's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Therasense's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Therasense's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Therasense helps investors to forecast how Therasense pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Therasense more accurately as focusing exclusively on Therasense's fundamentals will not take into account other important factors: Therasense Total Value Analysis
Therasense is at this time forecasted to have valuation of 27.3 M with market capitalization of 20.3 M, debt of 2.9 M, and cash on hands of 127.82 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Therasense fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
27.3 M | 20.3 M | 2.9 M | 127.82 K |
Therasense Investor Information
About 84.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.86. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Therasense recorded a loss per share of 0.0. The entity had not issued any dividends in recent years. The firm had a split on the 12th of September 2019. Based on the measurements of operating efficiency obtained from Therasense's historical financial statements, Therasense is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Therasense Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Therasense has an asset utilization ratio of 0.68 percent. This connotes that the Company is making $0.006793 for each dollar of assets. An increasing asset utilization means that Therasense is more efficient with each dollar of assets it utilizes for everyday operations.Therasense Ownership Allocation
Therasense shows a total of 6.15 Billion outstanding shares. Therasense has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 83.61 % of Therasense outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Therasense Profitability Analysis
The company reported the previous year's revenue of 353.26 K. Net Loss for the year was (7.75 M) with profit before overhead, payroll, taxes, and interest of 256.68 K.About Therasense Valuation
The pink sheet valuation mechanism determines Therasense's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Therasense based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Therasense. We calculate exposure to Therasense's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Therasense's related companies.Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. Theralink Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 16 people.
8 Steps to conduct Therasense's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Therasense's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Therasense's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Therasense's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Therasense's revenue streams: Identify Therasense's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Therasense's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Therasense's growth potential: Evaluate Therasense's management, business model, and growth potential.
- Determine Therasense's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Therasense's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Therasense Growth Indicators
Investing in growth stocks can be very risky. If the company such as Therasense does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Revenue Growth | -41.10% | |
| Float Shares | 1.01B |
Additional Tools for Therasense Pink Sheet Analysis
When running Therasense's price analysis, check to measure Therasense's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Therasense is operating at the current time. Most of Therasense's value examination focuses on studying past and present price action to predict the probability of Therasense's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Therasense's price. Additionally, you may evaluate how the addition of Therasense to your portfolios can decrease your overall portfolio volatility.